AstraZeneca PLCAZN:LSE

36.50 / 0.82%
3.76 %
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Nov 25 2015 17:08 GMT.


On Wednesday, AstraZeneca PLC (AZN:LSE) closed at 4,500, 8.75 % below its 52-week high of 4,931.68, set on Apr 22, 2015.

52-week range
Aug 24 2015
Apr 22 2015
Markit short selling activity
Day high4,505
Day low4,454.5
Previous close4,463.5
Average volume2.21m
Shares outstanding1.26bn
Free float1.26bn
P/E (TTM)50.37
Market cap56.56bn GBP
EPS (TTM)0.8885 GBP
Annual div (IAD)182.50 GBX
Annual div yield (IAD)4.09%
Div ex-dateAug 13 2015
Div pay-dateSep 14 2015
Data delayed at least 15 minutes, as of Nov 25 2015 17:08 GMT.
Last IC View
The last IC recommendation on AstraZeneca PLC shares was Hold at 4,202 on 12 Nov 2015
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC+2.06 %+10.58 %+0.70 %-3.76 %+47.61 %
FTSE 100 IDX+0.93 %-1.65 %-9.89 %-5.85 %+11.21 %
GB/HEALTH CARE+0.59 %+2.57 %-6.78 %-4.52 %+28.59 %
GB/PHARMACEUTICALS+0.58 %+2.92 %-7.14 %-4.79 %+27.32 %
Data delayed at least 15 minutes, as of Nov 25 2015 17:08 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.